Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

[Expert Profile] Ma Li, Chief Physician, Professor, Doctoral Supervisor, is a senior expert in rheumatology and immunology in China, working in the Department of Rheumatology, China-Japan Friendship Hospital. She has long been dedicated to the clinical diagnosis, treatment, and scientific research of difficult rheumatic diseases such as relapsing polychondritis and systemic vasculitis, and is an important expert in rheumatology in China.
[Education & Career] Professor Ma Li graduated from a renowned medical university, completed systematic clinical training at China-Japan Friendship Hospital, and has long been engaged in clinical, teaching, and research work in rheumatology. She has held academic positions including member of the Rheumatology Branch of the Chinese Medical Association, and has presided over multiple national and provincial research projects, accumulating extensive clinical experience in difficult vasculitis and rare immunological diseases.
[Areas of Expertise] Professor Ma specializes in the diagnosis and treatment of relapsing polychondritis, systemic vasculitis (takayasu arteritis, ANCA-associated vasculitis, etc.), polyarteritis nodosa, and various difficult rheumatic diseases. She has extensive experience in early identification, activity assessment, and immunosuppressive treatment of rare vasculitides. She excels at managing difficult cases associated with polychondritis such as "recurrent auricular swelling, nasal bridge collapse, and airway stenosis," helping numerous rare vasculitis patients receive clear diagnoses, control their conditions, and avoid organ damage.
[Academic Achievements & Industry Contributions] Professor Ma has led a series of clinical studies on relapsing polychondritis, systemic vasculitis, and related conditions, systematically summarizing the clinical features and treatment experiences of Chinese patients, with findings published in authoritative domestic and international journals. She has participated in the development of Chinese vasculitis and difficult rheumatology diagnosis and treatment guidelines, actively promoted standardized diagnosis and treatment of rare rheumatic diseases, and organized rare disease multidisciplinary consultations and patient education, making important contributions to improving the care standards for rare rheumatic diseases such as systemic vasculitis in China.
[Clinical Practice & Outstanding Contributions] For decades on the clinical front lines, Professor Ma has treated tens of thousands of patients with relapsing polychondritis and various difficult rheumatic diseases, providing clear diagnoses for numerous rare disease patients who "visited multiple hospitals." She is exceptionally patient and humanistic with patients, insisting on long-term follow-up and whole-course care, and is deeply trusted by patients. She has repeatedly organized rare disease science popularization lectures and free clinics, actively promoting social awareness of rare rheumatic diseases, and is a warm and reliable senior rheumatology expert in the hearts of patients.
[Honors & Reputation] Professor Ma Li has long held academic positions including Deputy Director of the Rheumatology Department at China-Japan Friendship Hospital. She has presided over grants from the National Natural Science Foundation of China and provincial and ministerial research programs, and is a senior expert in the field of rheumatology. She has profound expertise in the diagnosis and treatment of difficult rheumatic diseases such as relapsing polychondritis and systemic vasculitis. She has led clinical cohort research on rare vasculitis and chondritis, promoted standardized autoantibody testing and multidisciplinary collaborative diagnosis, and participated in the development of multiple rheumatology diagnosis and treatment guidelines and expert consensus statements. For decades on the clinical front lines, she has helped numerous difficult rheumatology patients who traveled across multiple regions receive clear diagnoses and standardized treatment, and is deeply trusted by patients and respected by peers alike.
|